Skip to content
Open access

Predicting MCI-to-Alzheimer’s Conversion: A Systematic Benchmark of Classical, Machine Learning, and Deep Survival Models

Oct 2026 · Diagnostics · 0 citations · 29 references

Abstract

Background/Objectives: Predicting time-to-conversion from mild cognitive impairment (MCI) to Alzheimer’s disease (AD) is a critical clinical challenge. Most survival analyses rely on static baseline variables, ignoring the temporal dynamics of serial neuroimaging. We benchmark seven survival model families using a novel temporal MRI descriptor pipeline on ADNI. Methods: A cohort of 661 MCI patients (250 conversion events, 37.8%, median follow-up 42.0 months) was constructed from ADNI. FreeSurfer volumetrics of six brain regions were summarised into three time-based descriptors each (atrophy rate, trajectory variability σ, and time-weighted cumulative mean μ) under strict anti-leakage constraints, yielding 18 neuroimaging features which, combined with six clinical variables (age, sex, education, MMSE, ADAS-13, and APOE-ε4), form a 24-dimensional covariate vector. Cox PH, Weibull AFT, Exponential, RSF, GBST, DeepSurv, and DeepHit were evaluated under stratified 5-fold cross-validation and assessed on an independent OASIS-3 cohort (n=78) as an exploratory analysis. Results: All seven models achieved C-index 0.853–0.863 (Δ=0.010), with Cox PH reaching 0.863±0.027 using only routine structural MRI. Time-dependent AUC ranged from 0.856 (12 months) to 0.938 (48 months). Risk stratification by quartile yielded highly separated Kaplan-Meier curves (log-rank p<0.001). On OASIS-3 (n=78, exploratory), classical models showed preliminary cross-cohort consistency (Weibull AFT 0.760±0.063, RSF 0.759±0.049), while deep learning degraded substantially (DeepSurv 0.551±0.116); these results are hypothesis-generating and should not be interpreted as confirmatory given the small per-fold sample size (EPV ≈ 1). Conclusions: The temporal MRI descriptor pipeline achieves a C-index of 0.863 using only routine structural MRI, without PET or CSF biomarkers, demonstrating strong discriminative performance on ADNI MCI-to-AD conversion. The narrow performance band (Δ=0.010) suggests that, within this feature-engineering paradigm, no clear performance separation was observed among the evaluated model architectures; this convergence may reflect feature-level rather than architecture-level constraints, although the underlying cause cannot be established from discriminative performance alone. Classical models showed more stable cross-cohort behaviour under data-scarce conditions; prospective validation on larger cohorts with full covariate parity is required before clinical translation can be considered.

Read PDF

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.